Expanding the Spectrum of Antibiotics Capable of Killing Multidrug-ResistantStaphylococcus aureusandPseudomonas aeruginosa
Expanding the Spectrum of Antibiotics Capable of Killing Multidrug-ResistantStaphylococcus aureusandPseudomonas aeruginosa
复制标题
DOI:
10.1002/cmdc.202000239
复制
发表时间:
2020-06-26
期刊:
影响因子:
3.4
通讯作者:
Rice, Charles V.
中科院分区:
文献类型:
--
作者:
Lam, Anh K.;Panlilio, Hannah;Rice, Charles V.
Infections from antibiotic-resistantStaphylococcus aureusandPseudomonas aeruginosaare a serious threat because reduced antibiotic efficacy complicates treatment decisions and prolongs the disease state in many patients. To expand the arsenal of treatments against antimicrobial-resistant (AMR) pathogens, 600-Da branched polyethylenimine (BPEI) can overcome antibiotic resistance mechanisms and potentiate beta-lactam antibiotics against Gram-positive bacteria. BPEI binds cell-wall teichoic acids and disables resistance factors from penicillin binding proteins PBP2a and PBP4. This study describes a new mechanism of action for BPEI potentiation of antibiotics generally regarded as agents effective against Gram-positive pathogens but not Gram-negative bacteria. 600-Da BPEI is able to reduce the barriers to drug influx and facilitate the uptake of a non-beta-lactam co-drug, erythromycin, which targets the intracellular machinery. Also, BPEI can suppress production of the cytokine interleukin IL-8 by human epithelial keratinocytes. This enables BPEI to function as a broad-spectrum antibiotic potentiator, and expands the opportunities to improve drug design, antibiotic development, and therapeutic approaches against pathogenic bacteria, especially for wound care.